Cathine
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
36393-56-3C[C@H](N)[C@@H](O)c1ccccc1DLNKOYKMWOXYQA-IONNQARKSA-NCathine is an amphetamine that is propylbenzene substituted by a hydroxy group at position 1 and by an amino group at position 2 (the 1S,2S-stereoisomer). It has a role as a central nervous system stimulant, a psychotropic drug and a plant metabolite. It is a member of amphetamines and a phenethylamine alkaloid.
DEA Schedule IV Controlled Substance -> Stimulants
Pharmaceuticals -> Metabolite of Pseudoephedrine
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
36393-56-3、492-39-7DTXSID20889399CHEMBL1412041CHEBI:4109